Funded Tech Companies

C2i Genomics

Looking for the VC firms that provided funding to C2i Genomics? Duquesne Capital Management, NFX and Section 32 put venture money into this healthcare IT company.

Company Overview

Contact Information

Company Background Information

Overview

C2i was formally founded in 2019 and is based on technology developed at Cornell and the New York Genome Center. We are backed by private investors. Our Company is headquartered in the US with an R&D center in Israel. We brought in the same outstanding people who developed the technology in academia, to build a successful team rapidly.

Profile

Social Media

Company News

Facebook

YouTube

Last Transaction

4/17/2021

Financing History

Management Team

Title

Name

Email & Social

Chief Executive Officer

Asaf Zviran

        

Chief Financial Officer

Ezra Sofer

        

Chief Technical Officer

Boris Oklander

        

VP - Bus. Development

Mark Oldroyd

        

VP - R & D

Ravi Kandasamy

        

Company Investors

• Duquesne Capital Management
• NFX (James Currier)
• Section 32
• iGlobe Partners
• Casdin Capital (Eli Casdin)
• Driehaus Capital Management
• The Mark Foundation for Cancer Research

Browse more funded tech companies:

C2FO | C2M Medical

Share this article

About Our Venture Capital Database

This tech company profile is powered by VentureDeal.com, a market leader in private equity transaction data.

Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary